Switch TZP: Metabolic Effects of Switching From Injectable Semaglutide to Tirzepatide (clinicaltrials.gov) - Oct 23, 2026 - P=N/A | N=650 | Active, not recruiting | Sponsor: LMC Diabetes & Endocrinology Ltd.
New trial • Diabetes • Genetic Disorders • Metabolic Disorders • Obesity • Type 2 Diabetes Mellitus
|